Gemcitabine-erlotinib regimen
Term · Oncology and biomedicine · MLC-T-ONC-003460
A chemotherapy combination used for the treatment of locally advanced and metastatic pancreatic cancer. It includes the drugs gemcitabine hydrochloride and erlotinib hydrochloride. Also called gemcitabine-Tarceva regimen.
A first-line chemotherapy regimen consisting of gemcitabine and erlotinib used for the treatment of locally advanced and metastatic pancreatic cancer.
| Identifier | MLC-T-ONC-003460 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | gemcitabine-Tarceva regimen |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-003460",
"term": "Gemcitabine-erlotinib regimen",
"field": "Oncology and biomedicine",
"definitions": [
"A chemotherapy combination used for the treatment of locally advanced and metastatic pancreatic cancer. It includes the drugs gemcitabine hydrochloride and erlotinib hydrochloride. Also called gemcitabine-Tarceva regimen.",
"A first-line chemotherapy regimen consisting of gemcitabine and erlotinib used for the treatment of locally advanced and metastatic pancreatic cancer."
],
"synonyms": [
"gemcitabine-Tarceva regimen"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/gemcitabine-erlotinib-regimen/"
}
Record 7,873 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.